Volume 7, Supplement 7Review ArticlesThe Development of Lonidamine for Benign Prostatic Hyperplasia and Other IndicationsClaus G RoehrbornBenign prostatic hyperplasiaHigh-grade prostatic intraepithelial neoplasiaLonidamineMetabolic targetingKrebs cycleCancer treatment